SDIX, LLC

SDIX is a wholly owned subsidiary of OriGene Technologies, specializing in high quality, large-scale GMP antibody production in 3 locations in the U.S.; 2 sites in Delaware and one in Maine. For over 25 years, SDIX has been a leading immuno-solutions company, developing results-oriented and innovative antibody-based solutions that enable customers, world-wide, to meet high performance diagnostic and commercialization objectives.  All 3 sites are ISO 13485:2003 certified and the manufacturing site in Delaware is FDA and MHRA registered for the manufacture and export of class I IHC reagents and kits.  For IHC applications, over 20 CE-marked IVD reagents are manufactured...